Company / Operating Margin
United Therapeutics Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
46.9%
FY2025
5-year range
33.0% / 50.9%
FY2021-FY2025
Trend
-2.0%
vs FY2024
Sector context
#4 of 136
Health Care
What the data says
Among 136 Health Care companies, United Therapeutics is in the top 3% for operating margin. Operating Margin has fluctuated over the past 10 years, ranging from -13.0% in FY2019 to 66.4% in FY2016.
Based on SEC 10-K filings.
46.9% in FY2025 with a 5-year CAGR of +6.9%. Top quartile in the Health Care sector.
Declined from 50.9% to 46.9% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -3.7pp
- 5-Year Change
- +6.9pp
- 10-Year Change
- -
Sector benchmark
Top 3% in Health CareTop 3% of 136This company 46.9% Sector average -778.9%
▼
+106.0% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 2.0% year-over-year.
- Currently 825.8pp above the Health Care sector average.
- Peak operating margin was recorded in FY2016.
- Lowest operating margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 46.9% | -2.0% |
| FY2024 | 47.9% | -6.0% |
| FY2023 | 50.9% | +0.6% |
| FY2022 | 50.6% | +53.4% |
| FY2021 | 33.0% | -17.6% |
| FY2020 | 40.0% | +409.0% |
| FY2019 | -13.0% | -126.2% |
| FY2018 | 49.5% | +3.8% |
| FY2017 | 47.7% | -28.2% |
| FY2016 | 66.4% | +39.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026